Group 1 - The core point of the article is that Xiansheng Pharmaceutical has conducted share buybacks, indicating a strategy to enhance shareholder value [1] - On January 16, the company repurchased 4.433 million shares at a price range of HKD 11.520 to HKD 11.773, totaling HKD 51.6328 million [1] - The stock closed at HKD 11.640 on the same day, reflecting a slight increase of 0.17% with a total trading volume of HKD 128 million [1] Group 2 - Year-to-date, the company has completed two buybacks, totaling 8.105 million shares and an aggregate amount of HKD 93.578 million [1] - The details of the buybacks include a previous transaction on January 12, where 3.672 million shares were repurchased at prices between HKD 11.198 and HKD 11.600, amounting to HKD 41.9453 million [1][2]
先声药业(02096.HK)1月16日回购443.30万股，耗资5163.28万港元